Hanmi Pharmaceutical Company Limited

This is the first study in people testing a new cancer drug called HM16390. Researchers want to find the safest and most effective dose, both by itself and combined with an existing immunotherapy drug (pembrolizumab). The trial will enroll 292 adults with advanced or metastatic s…

This is the first human study testing a new cancer drug called BH3120, both alone and combined with an existing immunotherapy drug (pembrolizumab). The trial aims to find safe doses and see if the treatment helps control advanced solid tumors that have spread or can't be removed …

This study is testing whether taking two oral drugs together, belvarafenib and cobimetinib, can help control advanced melanoma that has a specific genetic change called an NRAS mutation. It is for adults whose cancer has spread and for whom standard treatments have not worked or …

This study is testing whether a new weekly injection called HM15275 can help adults with obesity or overweight lose weight and is safe to use. About 250 participants without diabetes will receive either the drug or a placebo (inactive shot) for 36 weeks to compare results. The ma…

This study is testing whether an experimental injection called HM15912 is safe and can help adults with short bowel syndrome intestinal failure. Participants will receive either the drug or a placebo for up to 13 months to see if it improves how their bodies absorb nutrients. The…

This is the first study in humans to test the safety of a new experimental injection called HM17321, which is being developed for obesity. About 40 healthy adults will receive a single injection to see how their bodies react and process the drug. The main goal is to check for sid…